Ignite Creation Date:
2025-12-24 @ 7:38 PM
Ignite Modification Date:
2026-01-07 @ 8:11 AM
Study NCT ID:
NCT02692703
Status:
COMPLETED
Last Update Posted:
2021-07-13
First Post:
2016-02-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04-22
Start Date Type:
ACTUAL
Primary Completion Date:
2017-04-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-29
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-23
First Submit QC Date:
None
Study First Post Date:
2016-02-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-03-08
Results First Submit QC Date:
None
Results First Post Date:
2018-04-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-09
Last Update Post Date:
2021-07-13
Last Update Post Date Type:
ACTUAL